
Prior to the development of newer biologic medications, rheumatologists were relegated to using disease modifying anti-rheumatic drugs (DMARDS) to treat rheumatoid arthritis (RA).These DMARDS (drugs such as methotrexate, hydroxychloroquine [Plaquenil], sulfasalazine [Azulfidine]), were and continue to be helpful in reducing signs and symptoms of disease but do not have the…







